Literature DB >> 21418135

Hepatic resection for non-colorectal, non-neuroendocrine, non-sarcoma metastasis: a single-centre experience.

Ravi Marudanayagam1, Bynvant Sandhu, M Thamara P R Perera, Phillipe Taniere, Chris Coldham, Simon Bramhall, David Mayer, John Buckels, Darius Mirza.   

Abstract

BACKGROUND: The aim of the present study was to analyse the outcome after hepatic resection for non-colorectal, non-neuroendocrine, non-sarcomatous (NCNNNS) metastatic tumours and to identify the factors predicting survival.
METHODS: All patients who underwent hepatic resection for NCNNNS metastatic tumours between September 1996 and June 2009 were included. Patients' demographics, clinical and histopathological parameters, overall survival and the factors predicting survival were analysed.
RESULTS: In all, 65 patients underwent hepatic resection for metastasis. The most common site of a primary tumour was the kidney (24 patients). Fifteen patients had synchronous tumours. Fifty patients had major liver resections and 22 patients had bilobar disease. The median number of liver lesions resected was 1 and the median maximum diameter of the metastasis was 6 cm. A R0 resection was performed in 51 patients. The 1-, 3- and 5-year overall survival from the time of metastasectomy was 72.9%, 47.9% and 25.6%, respectively, with a median survival of 19 months. The presence of a tumour of greater than 6 cm (P= 0.048) and a positive resection margin (P= 0.04) were associated with poor survival.
CONCLUSION: Hepatic resection for metastasis from NCNNNS tumours can offer acceptable long-term survival in selected patients. To offer a chance of a cure a R0 resection must be performed.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 21418135      PMCID: PMC3081630          DOI: 10.1111/j.1477-2574.2010.00285.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  28 in total

1.  Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review.

Authors:  Süleyman Yedibela; Jonas Gohl; Valentina Graz; Mona Kathrin Pfaffenberger; Susanne Merkel; Werner Hohenberger; Thomas Meyer
Journal:  Ann Surg Oncol       Date:  2005-08-18       Impact factor: 5.344

2.  Non-colorectal, non-neuroendocrine, and non-sarcoma metastases of the liver: resection as a promising tool in the palliative management.

Authors:  Moritz Schmelzle; Claus F Eisenberger; Jan Schulte am Esch; Hanno Matthaei; Markus Krausch; Wolfram T Knoefel
Journal:  Langenbecks Arch Surg       Date:  2009-12-09       Impact factor: 3.445

3.  The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients.

Authors:  G Ercolani; G Vetrone; G L Grazi; M Cescon; P Di Gioia; M Ravaioli; M Del Gaudio; F Tuci; M Zanello; A Cucchetti; A D Pinna
Journal:  Minerva Chir       Date:  2009-12       Impact factor: 1.000

4.  Liver resection for colorectal metastases.

Authors:  Y Fong; A M Cohen; J G Fortner; W E Enker; A D Turnbull; D G Coit; A M Marrero; M Prasad; L H Blumgart; M F Brennan
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

5.  Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.

Authors:  Srinevas K Reddy; Andrew S Barbas; Carlos E Marroquin; Michael A Morse; Paul C Kuo; Bryan M Clary
Journal:  J Am Coll Surg       Date:  2007-03       Impact factor: 6.113

6.  Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis.

Authors:  Steven A Earle; Eduardo A Perez; Juan C Gutierrez; Danny Sleeman; Alan S Livingstone; Dido Franceschi; Joe U Levi; Craig Robbins; Leonidas G Koniaris
Journal:  J Am Coll Surg       Date:  2006-08-23       Impact factor: 6.113

Review 7.  Hepatic surgery for metastases from neuroendocrine tumors.

Authors:  Juan M Sarmiento; Florencia G Que
Journal:  Surg Oncol Clin N Am       Date:  2003-01       Impact factor: 3.495

8.  Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas.

Authors:  E H Ng; R E Pollock; M M Romsdahl
Journal:  Cancer       Date:  1992-03-15       Impact factor: 6.860

9.  Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

Authors:  Myrddin Rees; Paris P Tekkis; Fenella K S Welsh; Thomas O'Rourke; Timothy G John
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

Review 10.  Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases.

Authors:  Kurinchi Selvan Gurusamy; Rajarajan Ramamoorthy; Dinesh Sharma; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
View more
  6 in total

1.  Survival Benefits of Surgical Resection in Patients with Recurrent Biliary Tract Carcinoma.

Authors:  Hiroaki Motoyama; Akira Kobayashi; Takahide Yokoyama; Akira Shimizu; Noriyuki Kitagawa; Tsuyoshi Notake; Kentaro Fukushima; Hitoshi Masuo; Takahiro Yoshizawa; Shin-Ichi Miyagawa
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

Review 2.  The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review.

Authors:  Timothy L Fitzgerald; Jason Brinkley; Shannon Banks; Nasreen Vohra; Zachary P Englert; Emmanuel E Zervos
Journal:  Langenbecks Arch Surg       Date:  2014-08-23       Impact factor: 3.445

Review 3.  Metastatic liver disease from non-colorectal, non-neuroendocrine, non-sarcoma cancers: a systematic review.

Authors:  Fabio Uggeri; Paolo Alessandro Ronchi; Paolo Goffredo; Mattia Garancini; Luca Degrate; Luca Nespoli; Luca Gianotti; Fabrizio Romano
Journal:  World J Surg Oncol       Date:  2015-05-29       Impact factor: 2.754

4.  Laparoscopic liver resection for non-colorectal non-neuroendocrine metastases: perioperative and oncologic outcomes.

Authors:  Davit L Aghayan; Piotr Kalinowski; Airazat M Kazaryan; Åsmund Avdem Fretland; Mushegh A Sahakyan; Bård I Røsok; Egidijus Pelanis; Bjørn Atle Bjørnbeth; Bjørn Edwin
Journal:  World J Surg Oncol       Date:  2019-09-04       Impact factor: 2.754

5.  Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades.

Authors:  Oliver Beetz; Rabea Söffker; Sebastian Cammann; Felix Oldhafer; Florian W R Vondran; Florian Imkamp; Jürgen Klempnauer; Moritz Kleine
Journal:  Langenbecks Arch Surg       Date:  2020-01-14       Impact factor: 3.445

6.  Prognostic factors related to surgical outcome of liver metastases of breast cancer.

Authors:  Daniel V Kostov; Georgi L Kobakov; Daniel V Yankov
Journal:  J Breast Cancer       Date:  2013-06-28       Impact factor: 3.588

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.